EDP167
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EDP167, covering 2026-02-17 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Dose-exploration Study of EDP167 in HoFH [Phase 2]